Safety of Endoscopic Ultrasound-Guided Fine-Needle Aspiration for Pancreatic Solid Pseudopapillary Neoplasm Before Surgical Resection: A European Multicenter Registry-Based Study on 149 Patients.
Adenocarcinoma, Papillary
/ diagnosis
Adult
Aged
Endoscopic Ultrasound-Guided Fine Needle Aspiration
/ methods
Europe
Female
Humans
Male
Middle Aged
Neoplasm Recurrence, Local
Pancreatic Neoplasms
/ diagnosis
Preoperative Period
Registries
/ statistics & numerical data
Reproducibility of Results
Retrospective Studies
Risk Factors
Journal
Pancreas
ISSN: 1536-4828
Titre abrégé: Pancreas
Pays: United States
ID NLM: 8608542
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
entrez:
20
12
2019
pubmed:
20
12
2019
medline:
29
12
2020
Statut:
ppublish
Résumé
The results of only a few endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) for pancreatic solid pseudopapillary neoplasm (SPN) have been published, and the safety of the procedure has never been investigated. Our study compared the recurrence rate in patients with and without preoperative EUS-FNA. This European multicenter registry-based study was conducted in 22 digestive units, and retrospectively included all patients who underwent complete resection of a pancreatic SPN from 2000 to 2018. Patients with and without initial EUS-FNA were compared, and postsurgery recurrence and the associated risk factors were evaluated. A complete resection of a pancreatic SPN was performed in 149 patients (133 women, 89%), with a mean age of 34 (standard deviation, 14) years. There were no significant differences between the with (78 patients) and without (71 patients) EUS-FNA groups, except for age and tumor size and location.Preoperative EUS-FNA allowed pancreatic SPN diagnosis in 63/78 cases (81%). After a mean follow-up of 43 (standard deviation, 36) months, recurrence was noted in 4 patients (2.7%). Preoperative EUS-FNA was not correlated with recurrence, but an older age (P = 0.005) was significant. Preoperative EUS-FNA does not affect pancreatic SPN recurrence. In this series, old age was significantly correlated with recurrence.
Identifiants
pubmed: 31856077
doi: 10.1097/MPA.0000000000001460
pii: 00006676-202001000-00002
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
34-38Références
Frantz VK. Tumors of the pancreas. In: Atlas of Tumor Pathology, Section VII, Fascicles 27 and 28. Washington, DC: US Armed Forces Institute of Pathology; 1959:32–33.
Klöppel G, Heitz PU, Capella C, et al. Pathology and nomenclature of human gastrointestinal neuroendocrine (carcinoid) tumors and related lesions. World J Surg. 1996;20:132–141.
Reddy S, Cameron JL, Scudiere J, et al. Surgical management of solid-pseudopapillary neoplasms of the pancreas (Franz or Hamoudi tumors): a large single-institutional series. J Am Coll Surg. 2009;208:950–957; discussion 957–959.
Kim CW, Han DJ, Kim J, et al. Solid pseudopapillary tumor of the pancreas: can malignancy be predicted? Surgery. 2011;149:625–634.
Butte JM, Brennan MF, Gönen M, et al. Solid pseudopapillary tumors of the pancreas. Clinical features, surgical outcomes, and long-term survival in 45 consecutive patients from a single center. J Gastrointest Surg. 2011;15:350–357.
Machado MC, Machado MA, Bacchella T, et al. Solid pseudopapillary neoplasm of the pancreas: distinct patterns of onset, diagnosis, and prognosis for male versus female patients. Surgery. 2008;143:29–34.
Yang F, Jin C, Long J, et al. Solid pseudopapillary tumor of the pancreas: a case series of 26 consecutive patients. Am J Surg. 2009;198:210–215.
Law JK, Ahmed A, Singh VK, et al. A systematic review of solidpseudopapillary neoplasms: are these rare lesions? Pancreas. 2014;43:331–337.
Papavramidis T, Papavramidis S. Solid pseudopapillary tumors of the pancreas: review of 718 patients reported in English literature. J Am Coll Surg. 2005;200:965–972.
Yu PF, Hu ZH, Wang XB, et al. Solid pseudopapillary tumor of the pancreas: a review of 553 cases in Chinese literature. World J Gastroenterol. 2010;16:1209–1214.
Salla C, Chatzipantelis P, Konstantinou P, et al. Endoscopic ultrasound-guided fine-needle aspiration cytology diagnosis of solid pseudopapillary tumor of the pancreas: a case report and literature review. World J Gastroenterol. 2007;13:5158–5163.
Law JK, Stoita A, Wever W, et al. Endoscopic ultrasound-guided fine needle aspiration improves the pre-operative diagnostic yield of solid-pseudopapillary neoplasm of the pancreas: an international multicenter case series (with video). Surg Endosc. 2014;28:2592–2598.
Hosokawa I, Shimizu H, Ohtsuka M, et al. Preoperative diagnosis and surgical management for solid pseudopapillary neoplasm of the pancreas. J Hepatobiliary Pancreat Sci. 2014;21:573–578.
Burford H, Baloch Z, Liu X, et al. E-caderin/beta-catenin and CD10: a limited immunohistochemical panel to distinguish pancreatic endocrine neoplasm of the pancreas on endoscopic ultrasound-guided fineneedle aspirates of the pancreas. Am J Clin Pathol. 2009;132:831–839.
Lévy P, Auber A, Ruszniewski P. Do not biopsy solid pseudopapillary tumors of the pancreas! Endoscopy. 2008;40:959.
Kim MJ, Jang SJ, Yu E. Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas. Hum Pathol. 2008;39:251–258.
Matsunou H, Konishi F. Papillary-cystic neoplasm of the pancreas. A clinicopathologic study concerning the tumor aging and malignancy of nine cases. Cancer. 1990;65:283–291.
Ansari D, Elebro J, Tingstedt B, et al. Single-institution experience with solid pseudopapillary neoplasm of the pancreas. Scand J Gastroenterol. 2011;46:1492–1497.
Tang LH, Aydin H, Brennan MF, et al. Clinically aggressive solid pseudopapillary tumors of the pancreas: a report of two cases with components of undifferentiated carcinoma and a comparative clinicopathologic analysis of 34 conventional cases. Am J Surg Pathol. 2005;29:512–519.